| Dec'17 | Dec'16 | |||||
|---|---|---|---|---|---|---|
Cash flow provided by (used in) Operating activities | ||||||
Net loss for the year | ||||||
-70,792 | -23,295 | |||||
Adjustments for | ||||||
Amortization of deferred revenue | ||||||
-118 | -168 | |||||
Amortization of property and equipment | ||||||
22 | 22 | |||||
Amortization of acquired intellectual property and other intangible assets | ||||||
1,434 | 1,457 | |||||
Change in value of short term investments (note 17) | ||||||
67 | 0 | |||||
Revaluation of contingent consideration | ||||||
502 | 1,630 | |||||
Loss (gain) on disposal of equipment | ||||||
-1 | 19 | |||||
Change in estimated fair value of derivative warrant liabilities | ||||||
-23,924 | 1,732 | |||||
Stock-based compensation | ||||||
4,242 | 1,383 | |||||
Share issue costs allocated to derivative warrants | ||||||
0 | 655 | |||||
Change in provision for restructuring costs | ||||||
0 | 116 | |||||
Adjustments to reconcile profit (loss) | ||||||
-40,718 | -20,183 | |||||
Contingent consideration milestones paid | ||||||
2,150 | 0 | |||||
Net change in other operating assets and liabilities (note 17) | ||||||
-1,699 | -1,470 | |||||
Net cash used in operating activities | ||||||
-41,169 | -18,713 | |||||
Investing activities (note 17) | ||||||
Purchase of short term investments | ||||||
97,996 | 21,138 | |||||
Proceeds on disposal/maturity of short term investments | ||||||
90,018 | 31,135 | |||||
Proceeds on disposal of equipment | ||||||
0 | 19 | |||||
Purchase of equipment | ||||||
25 | 15 | |||||
Capitalized patent costs | ||||||
0 | 10 | |||||
Net cash generated from (used in) investing activities | ||||||
-8,003 | 9,991 | |||||
Financing activities (note 17) | ||||||
Net proceeds from issuance of common shares | ||||||
162,324 | 7,821 | |||||
Net proceeds from issuance of bought deal units | ||||||
0 | 26,142 | |||||
Net proceeds from issuance of private placement units | ||||||
0 | 6,640 | |||||
Proceeds from exercise of derivative warrants | ||||||
8,684 | 0 | |||||
Proceeds from exercise of warrants | ||||||
232 | 1,905 | |||||
Proceeds from exercise of stock options | ||||||
3,912 | 107 | |||||
Net cash generated from financing activities | ||||||
175,152 | 42,615 | |||||
Increase in cash and cash equivalents during the year | ||||||
125,980 | 33,893 | |||||